Greater Cannabis Company (GCAN) Non-Current Debt (2020 - 2023)

Greater Cannabis Company's (GCAN) quarterly Non-Current Debt came in at $36000.0 in Q3 2023, down 73.33% year-on-year from $135000.0 in Q3 2022, and down 73.33% quarter-over-quarter from $135000.0 in Q3 2022.

Greater Cannabis Company (GCAN) Non-Current Debt (2020 - 2023) Analysis & Trends

Greater Cannabis Company's Non-Current Debt history runs 4 years deep, the most recent figure standing at $36000.0 for Q3 2023.

  • On a quarterly basis, Non-Current Debt fell 73.33% year-over-year to $36000.0 in Q3 2023; TTM through Sep 2023 was $36000.0, a 73.33% decrease from a year earlier, with the FY2020 full-year figure at $325212.0, changed N/A from the prior year.
  • Non-Current Debt slipped to $36000.0 in Q3 2023 per GCAN's latest filing, from $135000.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $325212.0 in Q4 2020 and bottomed at $22500.0 in Q1 2021.
  • The 4-year median for Non-Current Debt is $101041.0 (2020), against an average of $142074.4.
  • Across the five-year window, Non-Current Debt tumbled 86.39% in 2021 and rose 11.11% in 2022, its largest moves.
  • Year by year, Non-Current Debt stood at $325212.0 in 2020, then dropped by 4.35% to $311050.0 in 2021, then tumbled by 56.6% to $135000.0 in 2022, then tumbled by 73.33% to $36000.0 in 2023.
  • Per Business Quant, the three latest GCAN Non-Current Debt figures stand at $36000.0 (Q3 2023), $135000.0 (Q3 2022), and $25000.0 (Q2 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 10.34 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 14.02 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 27.86 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 12.41 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.74 Bn
10 Greater Cannabis Company 292,929.85 292,929.85 - -

Historic Data

Download Data
DateValue
Sep 30, 2023 36,000.00
Sep 30, 2022 135,000.00
Jun 30, 2022 25,000.00
Sep 30, 2021 311,050.00
Jun 30, 2021 22,500.00
Mar 31, 2021 22,500.00
Dec 31, 2020 325,212.00
Sep 30, 2020 311,050.00
Jun 30, 2020 67,082.00
Mar 31, 2020 165,350.00